Report Detail

Pharma & Healthcare Global and Japan Neuroprotective Products Market Insights, Forecast to 2026

  • RnM4203202
  • |
  • 14 September, 2020
  • |
  • Global
  • |
  • 126 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Neuroprotective Products Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Neuroprotective Products Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Neuroprotective Products Market Size Growth Rate by Type
    • 1.4.2 Cholinesterase inhibitors
    • 1.4.3 NMDA receptor antagonists
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Neuroprotective Products Market Size Growth Rate by Application
    • 1.5.2 Alzheimer's disease
    • 1.5.3 Multiple sclerosis
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Neuroprotective Products Market Size, Estimates and Forecasts
    • 2.1.1 Global Neuroprotective Products Revenue 2015-2026
    • 2.1.2 Global Neuroprotective Products Sales 2015-2026
  • 2.2 Global Neuroprotective Products, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Neuroprotective Products Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Neuroprotective Products Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Neuroprotective Products Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Neuroprotective Products Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Neuroprotective Products Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Neuroprotective Products Revenue Forecast by Region (2021-2026)

3 Global Neuroprotective Products Competitor Landscape by Players

  • 3.1 Global Top Neuroprotective Products Sales by Manufacturers
    • 3.1.1 Global Neuroprotective Products Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Neuroprotective Products Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Neuroprotective Products Manufacturers by Revenue
    • 3.2.1 Global Neuroprotective Products Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Neuroprotective Products Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Neuroprotective Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Neuroprotective Products Revenue in 2019
    • 3.2.5 Global Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Neuroprotective Products Price by Manufacturers
  • 3.4 Global Neuroprotective Products Manufacturing Base Distribution, Product Types
    • 3.4.1 Neuroprotective Products Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Neuroprotective Products Product Type
    • 3.4.3 Date of International Manufacturers Enter into Neuroprotective Products Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Neuroprotective Products Market Size by Type (2015-2020)
    • 4.1.1 Global Neuroprotective Products Sales by Type (2015-2020)
    • 4.1.2 Global Neuroprotective Products Revenue by Type (2015-2020)
    • 4.1.3 Neuroprotective Products Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Neuroprotective Products Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Neuroprotective Products Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Neuroprotective Products Revenue Forecast by Type (2021-2026)
    • 4.2.3 Neuroprotective Products Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Neuroprotective Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Neuroprotective Products Market Size by Application (2015-2020)
    • 5.1.1 Global Neuroprotective Products Sales by Application (2015-2020)
    • 5.1.2 Global Neuroprotective Products Revenue by Application (2015-2020)
    • 5.1.3 Neuroprotective Products Price by Application (2015-2020)
  • 5.2 Neuroprotective Products Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Neuroprotective Products Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Neuroprotective Products Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Neuroprotective Products Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Neuroprotective Products Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Neuroprotective Products Sales YoY Growth 2015-2026
    • 6.1.2 Japan Neuroprotective Products Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Neuroprotective Products Market Share in Global Market 2015-2026
  • 6.2 Japan Neuroprotective Products Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Neuroprotective Products Players by Sales (2015-2020)
    • 6.2.2 Japan Top Neuroprotective Products Players by Revenue (2015-2020)
  • 6.3 Japan Neuroprotective Products Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Neuroprotective Products Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Neuroprotective Products Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Neuroprotective Products Price by Type (2015-2020)
  • 6.4 Japan Neuroprotective Products Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Neuroprotective Products Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Neuroprotective Products Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Neuroprotective Products Price Forecast by Type (2021-2026)
  • 6.5 Japan Neuroprotective Products Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Neuroprotective Products Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Neuroprotective Products Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Neuroprotective Products Price by Application (2015-2020)
  • 6.6 Japan Neuroprotective Products Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Neuroprotective Products Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Neuroprotective Products Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Neuroprotective Products Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Neuroprotective Products Market Size YoY Growth 2015-2026
  • 7.2 North America Neuroprotective Products Market Facts & Figures by Country
    • 7.2.1 North America Neuroprotective Products Sales by Country (2015-2020)
    • 7.2.2 North America Neuroprotective Products Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Neuroprotective Products Market Size YoY Growth 2015-2026
  • 8.2 Europe Neuroprotective Products Market Facts & Figures by Country
    • 8.2.1 Europe Neuroprotective Products Sales by Country
    • 8.2.2 Europe Neuroprotective Products Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Neuroprotective Products Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Neuroprotective Products Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Neuroprotective Products Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Neuroprotective Products Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Neuroprotective Products Market Size YoY Growth 2015-2026
  • 10.2 Latin America Neuroprotective Products Market Facts & Figures by Country
    • 10.2.1 Latin America Neuroprotective Products Sales by Country
    • 10.2.2 Latin America Neuroprotective Products Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Neuroprotective Products Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Neuroprotective Products Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Neuroprotective Products Sales by Country
    • 11.2.2 Middle East and Africa Neuroprotective Products Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Genervon Biopharmaceuticals (Canada)
    • 12.1.1 Genervon Biopharmaceuticals (Canada) Corporation Information
    • 12.1.2 Genervon Biopharmaceuticals (Canada) Description and Business Overview
    • 12.1.3 Genervon Biopharmaceuticals (Canada) Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Products Offered
    • 12.1.5 Genervon Biopharmaceuticals (Canada) Recent Development
  • 12.2 NeuroVive Pharmaceutical (Sweden)
    • 12.2.1 NeuroVive Pharmaceutical (Sweden) Corporation Information
    • 12.2.2 NeuroVive Pharmaceutical (Sweden) Description and Business Overview
    • 12.2.3 NeuroVive Pharmaceutical (Sweden) Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Products Offered
    • 12.2.5 NeuroVive Pharmaceutical (Sweden) Recent Development
  • 12.3 Ceregene (USA)
    • 12.3.1 Ceregene (USA) Corporation Information
    • 12.3.2 Ceregene (USA) Description and Business Overview
    • 12.3.3 Ceregene (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Ceregene (USA) Neuroprotective Products Products Offered
    • 12.3.5 Ceregene (USA) Recent Development
  • 12.4 BHRPharma (Thailand)
    • 12.4.1 BHRPharma (Thailand) Corporation Information
    • 12.4.2 BHRPharma (Thailand) Description and Business Overview
    • 12.4.3 BHRPharma (Thailand) Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 BHRPharma (Thailand) Neuroprotective Products Products Offered
    • 12.4.5 BHRPharma (Thailand) Recent Development
  • 12.5 Neuren Pharmaceuticals (Australia)
    • 12.5.1 Neuren Pharmaceuticals (Australia) Corporation Information
    • 12.5.2 Neuren Pharmaceuticals (Australia) Description and Business Overview
    • 12.5.3 Neuren Pharmaceuticals (Australia) Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Neuren Pharmaceuticals (Australia) Neuroprotective Products Products Offered
    • 12.5.5 Neuren Pharmaceuticals (Australia) Recent Development
  • 12.6 Allon therapeutics (Canada)
    • 12.6.1 Allon therapeutics (Canada) Corporation Information
    • 12.6.2 Allon therapeutics (Canada) Description and Business Overview
    • 12.6.3 Allon therapeutics (Canada) Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Allon therapeutics (Canada) Neuroprotective Products Products Offered
    • 12.6.5 Allon therapeutics (Canada) Recent Development
  • 12.7 Bionure Inc. (USA)
    • 12.7.1 Bionure Inc. (USA) Corporation Information
    • 12.7.2 Bionure Inc. (USA) Description and Business Overview
    • 12.7.3 Bionure Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Bionure Inc. (USA) Neuroprotective Products Products Offered
    • 12.7.5 Bionure Inc. (USA) Recent Development
  • 12.11 Genervon Biopharmaceuticals (Canada)
    • 12.11.1 Genervon Biopharmaceuticals (Canada) Corporation Information
    • 12.11.2 Genervon Biopharmaceuticals (Canada) Description and Business Overview
    • 12.11.3 Genervon Biopharmaceuticals (Canada) Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Products Offered
    • 12.11.5 Genervon Biopharmaceuticals (Canada) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Neuroprotective Products Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Neuroprotective Products Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Neuroprotective Products market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Neuroprotective Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Neuroprotective Products market is segmented into
    Cholinesterase inhibitors
    NMDA receptor antagonists
    Others

    Segment by Application, the Neuroprotective Products market is segmented into
    Alzheimer's disease
    Multiple sclerosis
    Others

    Regional and Country-level Analysis
    The Neuroprotective Products market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Neuroprotective Products market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Neuroprotective Products Market Share Analysis
    Neuroprotective Products market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuroprotective Products business, the date to enter into the Neuroprotective Products market, Neuroprotective Products product introduction, recent developments, etc.
    The major vendors covered:
    Genervon Biopharmaceuticals (Canada)
    NeuroVive Pharmaceutical (Sweden)
    Ceregene (USA)
    BHRPharma (Thailand)
    Neuren Pharmaceuticals (Australia)
    Allon therapeutics (Canada)
    Bionure Inc. (USA)
    ...


    Summary:
    Get latest Market Research Reports on Neuroprotective Products. Industry analysis & Market Report on Neuroprotective Products is a syndicated market report, published as Global and Japan Neuroprotective Products Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Neuroprotective Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,032.54
    4,548.81
    6,065.09
    3,327.91
    4,991.86
    6,655.81
    411,820.50
    617,730.75
    823,641.00
    287,504.10
    431,256.15
    575,008.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report